Ms. Carol Gershaw

New York, NY [September 16, 2002] C3i, the leading provider of customer management solutions to the life sciences industry, announced that Carol Gershaw will join its Board of Directors. In addition to receiving a seat on the Board, Ms. Gershaw will provide strategic advice on several company initiatives. Ms. Gershaw will join the C3i team with extensive pharmaceutical experience as well as a history of working with C3i while she was an executive at Schering-Plough.

"Having worked with C3i for several years as one of their clients, I was both excited and honored when they extended me an invitation to join their Board of Directors. C3i has a proven reputation for providing comprehensive customer management services to the life sciences industry. I look forward to continuing my relationship with C3i, both as a Board Member and strategic advisor," commented Carol Gershaw.

Ms. Gershaw comes to the C3i Board after a career at Schering-Plough spanning two decades. While there, she held several positions, including Regional Director of Managed Care Sales and Vice President of Sales and Marketing Planning and Analysis. Ms. Gershaw concluded her career at Schering-Plough as the Vice President of Information Technology. Since leaving Schering-Plough, Ms. Gershaw founded Beacon Pointe Group, a consulting firm specializing in sales, marketing and business strategy for the life sciences industry. She currently provides consulting services to several leading pharmaceutical organizations. Aside from her roles within the pharmaceutical industry, Ms. Gershaw is Director of the New Jersey Attorney Disciplinary Oversight Committee, where she is the Chairperson of the Budget Committee. Ms. Gershaw holds a Bachelors degree in Biology and an M.B.A. from Rutgers University.

New York, NY [September 16, 2002] C3i, the leading provider of customer management solutions to the life sciences industry, announced that Carol Gershaw will join its Board of Directors. In addition to receiving a seat on the Board, Ms. Gershaw will provide strategic advice on several company initiatives. Ms. Gershaw will join the C3i team with extensive pharmaceutical experience as well as a history of working with C3i while she was an executive at Schering-Plough.

"Having worked with C3i for several years as one of their clients, I was both excited and honored when they extended me an invitation to join their Board of Directors. C3i has a proven reputation for providing comprehensive customer management services to the life sciences industry. I look forward to continuing my relationship with C3i, both as a Board Member and strategic advisor," commented Carol Gershaw.

Ms. Gershaw comes to the C3i Board after a career at Schering-Plough spanning two decades. While there, she held several positions, including Regional Director of Managed Care Sales and Vice President of Sales and Marketing Planning and Analysis. Ms. Gershaw concluded her career at Schering-Plough as the Vice President of Information Technology. Since leaving Schering-Plough, Ms. Gershaw founded Beacon Pointe Group, a consulting firm specializing in sales, marketing and business strategy for the life sciences industry. She currently provides consulting services to several leading pharmaceutical organizations. Aside from her roles within the pharmaceutical industry, Ms. Gershaw is Director of the New Jersey Attorney Disciplinary Oversight Committee, where she is the Chairperson of the Budget Committee. Ms. Gershaw holds a Bachelors degree in Biology and an M.B.A. from Rutgers University.
...
Carol easily exceeds these criteria and represents a tremendous addition to our organization.

Carol Gershaw Myers , Beacon Pointe Group, LLC

Carol Gershaw, Cofounder, Beacon Pointe Group Gershaw, who founded the Beacon Pointe Group in 2002, previously spent 15 years at Schering-Plough, where she held various positions of increasing responsibility, including assistant controller; senior director of sourcing and manufacturing strategic planning; regional director of managed care sales; VP of sales, marketing, planning, and analysis; and most recently, VP of information technology. A respected team builder who has managed operating and capital budgets in excess of $150 million, Gershaw was recently named to the board of C3i and appointed by the chief justice of the New Jersey Supreme Court to serve as a director of the disciplinary oversight committee; Gershaw currently serves as chairperson for the organization's budget committee. She holds an M.B.A. in finance and a B.S. in biology from Rutgers University.

Carol Gershaw | Jay Goldberg | Mark Hoffman
...
Carol Gershaw - Co-Founder, Beacon Pointe Group

Co-founder of Beacon Pointe Group since 2002, Carol provides high-level management expertise to executives in the pharmaceutical industry.

Before creating the Beacon Pointe Group, Carol spent a large portion of her career with Schering Plough, where she held various positions of increasing responsibility over the last 15 years.Serving most recently as Vice President of Information Technology, Carol was responsible for strategic planning and operational support for all IT applications used by the global pharmaceutical business.Her responsibilities involved understanding the business issues facing the various divisions (manufacturing, sales, marketing and finance) and leveraging technology to help solve their issues.

Carol also served as the Vice President of Sales, Marketing Planning and Analysis at Schering Plough.In this capacity, Carol was responsible for strategic direction and operational support for over 4000 pharmaceutical sales representatives.During her career at Schering Plough, she also held other significant leadership positions within a number of different disciplines including: Regional Director of Managed Care Sales, Senior Director of Sourcing and Manufacturing Strategic Planning and Assistant Controller.Carol has managed teams of over 400 people and operating and capital budgets of over $150 MM.

In addition to being a well respected team builder within her own company, Carol has a proven ability to build effective relationships with CEOs, CFOs and the executive teams of clients such as United Healthcare, Diversified Pharmaceutical Services, PCS, Express Scripts as well as other key stakeholders.

Carol was recently appointed to the Board of Directors of C3i; a privately held firm specializing in technological support of pharmaceutical sales teams.She was also appointed by the Chief Justice of the New Jersey Supreme Court to serve as a Director of the Disciplinary Oversight Committee, a board which supervises the state attorney discipline system.She currently serves as Chairperson for the organization's budget committee.

Carol holds an MBA in Finance and a B.S. in Biology from Rutgers University.

Carol Gershaw | Jay Goldberg | Mark Hoffman
...
Carol Gershaw - Co-Founder, Beacon Pointe Group

Co-founder of Beacon Pointe Group since 2002, Carol provides high-level management expertise to executives in the pharmaceutical industry.

Before creating the Beacon Pointe Group, Carol spent a large portion of her career with Schering Plough, where she held various positions of increasing responsibility over the last 15 years.Serving most recently as Vice President of Information Technology, Carol was responsible for strategic planning and operational support for all IT applications used by the global pharmaceutical business.Her responsibilities involved understanding the business issues facing the various divisions (manufacturing, sales, marketing and finance) and leveraging technology to help solve their issues.

Carol also served as the Vice President of Sales, Marketing Planning and Analysis at Schering Plough.In this capacity, Carol was responsible for strategic direction and operational support for over 4000 pharmaceutical sales representatives.During her career at Schering Plough, she also held other significant leadership positions within a number of different disciplines including: Regional Director of Managed Care Sales, Senior Director of Sourcing and Manufacturing Strategic Planning and Assistant Controller.Carol has managed teams of over 400 people and operating and capital budgets of over $150 MM.

In addition to being a well respected team builder within her own company, Carol has a proven ability to build effective relationships with CEOs, CFOs and the executive teams of clients such as United Healthcare, Diversified Pharmaceutical Services, PCS, Express Scripts as well as other key stakeholders.

Carol was recently appointed to the Board of Directors of C3i; a privately held firm specializing in technological support of pharmaceutical sales teams.She was also appointed by the Chief Justice of the New Jersey Supreme Court to serve as a Director of the Disciplinary Oversight Committee, a board which supervises the state attorney discipline system.She currently serves as Chairperson for the organization's budget committee.

Carol holds an MBA in Finance and a B.S. in Biology from Rutgers University.

NEW YORK, NY - December 12, 2003 - Marketing Technology Solutions Inc. (MTS), a consumer-marketing information company, announced today that Carol Gershaw will join its Board of Directors.Ms. Gershaw is a former pharmaceutical industry executive who will provide strategic advice on key company initiatives.She currently runs her own consulting firm, Beacon Pointe Group, which provides sales, marketing and business strategy for several leading pharmaceutical organizations.

Prior to establishing the Beacon Pointe Group in 2002, Carol spent a large portion of her career with Schering-Plough, where she held various positions over a 15 year period.As Vice President of Information Technology, Ms. Gershaw was responsible for the strategic planning of all IT applications used by Schering-Plough.She previously also served as Vice President of Sales, Marketing Planning and Analysis, overseeing operational support for thousands of pharmaceutical sales representatives.During her career at Schering-Plough, Ms. Gershaw also held other significant leadership positions including: Regional Director of Managed Care Sales and Senior Director of Sourcing and Manufacturing, Strategic Planning.Carol has managed teams of hundreds, operating capital budgets of over $150 million.
...
In addition to being a well respected team builder within Schering-Plough, Carol has a proven ability to build effective relationships with CEOs, CFOs and the executive teams of clients such as United Healthcare, Diversified Pharmaceutical Services, PCS, Express Scripts as well as other key stakeholders.In 2002 Carol was appointed to the Board of Directors of C3i; a privately held firm specializing in technological support of pharmaceutical sales teams.She was also appointed by the Chief Justice of the New Jersey Supreme Court to serve as a Director of the Disciplinary Oversight Committee, a board which supervises the state attorney discipline system.She currently serves as Chairperson for the organization's budget committee.

Carol holds an MBA in Finance and a B.S. in Biology from Rutgers University.